Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.

Manoj Upadhya

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.'. Together they form a unique fingerprint.

Medicine & Life Sciences